Cabinet grants Gesy access to foreign nationals without paperwork (Updated)
The cabinet on Wednesday agreed on temporary measures to allow access to the services of the national health scheme (Gesy) to those beneficiaries who have
Health
Gesy software leading to lab test errors
The providers of the national health scheme (Gesy) will need continuous training on the new digital system, the association of clinical laboratories said on Tuesday
EU nationals still struggling to register with Gesy
Thousands of European foreign nationals living in Cyprus and who require specific residence permits to register with the national health scheme (Gesy) are stuck in
Gesy passes first big test day (Update 2)
No major problems were recorded on Monday as more than 4,500 people sought medical help, putting the health system (Gesy) through its paces after its
Rogue Chinese scientist made ‘foolish’ choice in gene-edited babies
By Kate Kelland A rogue Chinese scientist who caused outrage last year when he said he had created the world’s first “gene-edited” babies in
Scientists edit chicken genes to make them resistant to bird flu
Scientists in Britain have used gene-editing techniques to stop bird flu spreading in chicken cells grown in a lab – a key step towards making
New health scheme put to the test (Updated)
The new univiersal health system (Gesy) was put to its first real test on Monday after its official launch on Saturday with thousands flocking to
‘Biggest social reform since 1960’ off to a good start officials say (Update 2)
IN WHAT was hailed as an historic day by President Nicos Anastasiades, Cyprus on Saturday introduced universal health care (Gesy), in what is perhaps the
Gesy is ‘not ideal’ but it’s going ahead, minister says
On the eve of the introduction of the first phase of Gesy on Saturday, Health Minister Constantinos Ioannou warned there would be problems as doctors
Contingency plans drawn up in case of Gesy problems
The health insurance organisation (HIO) has made contingency plans to tackle potential problems arising from the introduction of the national health scheme (Gesy) on Saturday,
Police launch campaign to stop sale of tobacco to minors
Police launched an island-wide campaign on Friday to clamp down on the illegal sale of tobacco to minors on the occasion of World No Tobacco
HNB – Abortion to be prohibited after embryonic heartbeat detection
The Louisiana House of Representatives voted on Wednesday to prohibit abortion after detection of an embryonic heartbeat, which can occur as early as six weeks from
Presidential call to support Gesy ‘revolution’ as kick-off date looms
Health Minister Constantinos Ioannou said Thursday the government has no intention of postponing the implementation of the national health scheme (Gesy), as various sides continued
Health news in brief
Teens are more likely to get at least one of two recommended doses of the meningococcal vaccine when they receive their first shot by early
Gesy guidelines for transition period after June 1 launch
The health ministry on Wednesday issued guidelines concerning services from public hospitals after June 1 when the first phase of the National Health Scheme (Gesy)
Pharmacies concerned over drug shortages and software glitches
Authorities played down fears on Wednesday of delays in supplying drugs to Gesy pharmacies after the national health scheme kicks in on June 1. They
Preliminary Gesy list of over 1,000 drugs drawn up
A preliminary list of over 1,000 pharmaceutical products that will stock Gesy pharmacies was released on Tuesday. With just a few more days to go
Scientists zoom in on bug behind Strep throat and scarlet fever
By Kate Kelland, Health and Science Correspondent LONDON, May 27 (Reuters) – Scientists studying a bacterium that causes scarlet fever, severe sore throat and a form of
How safe are we from a measles epidemic?
The lack of a national database, unreliable surveys and the disconnect between the private and public health sectors mean we do not actually know. As
Novartis $2m gene therapy is world’s most expensive drug
Swiss drugmaker Novartis on Friday won U.S. approval for its gene therapy Zolgensma for spinal muscular atrophy (SMA), the leading genetic cause of death in
